Clinical Research Expertise Across Diverse Therapeutic Areas

MERCLINCO supports clinical trials across infectious diseases, vaccines, respiratory conditions, chronic diseases and specialised therapeutic areas through experienced investigators and established research sites across Africa.
Our sites and investigators bring extensive experience across Phase II–IV clinical trials, supporting studies within diverse healthcare environments and patient populations across Africa.
Expertise Across High-Need
Therapeutic Areas

MERCLINCO supports clinical trials across multiple therapeutic areas relevant to both regional and global healthcare priorities.

Our sites and investigators bring extensive experience in conducting Phase II–IV studies across diverse patient populations and healthcare environments.

Infectious Diseases

  • HIV/AIDS
  • Tuberculosis (TB)
  • Hepatitis B & C
  • Respiratory infection

Vaccine Studies

  • TB vaccines
  • HIV vaccine studies
  • RSV and Influenza
  • COVID-19 studies

Respiratory Conditions

  • Asthma
  • COPD
  • Respiratory infections

Chronic Diseases

  • Type 1 & Type 2 Diabetes
  • Obesity
  • Cardiovascular conditions
  • Osteoarthritis

Women’s Health

  • Menopause
  • Endometriosis
  • Women’s healthcare studies

Dermatology

  • Atopic dermatitis
  • Fungal infections
  • Skin infections

Gastroenterology

  • GORD
  • IBS

Rheumatology

  • Rheumatoid arthritis
  • Gout
  • Osteoarthritis

Sexual Health

  • Erectile Dysfunction
  • Sexually Transmitted Diseases
  • Sexual health & related conditions
Infectious Disease & Vaccine Trial Experience

MERCLINCO has extensive experience supporting infectious disease and vaccine studies across diverse African patient populations and healthcare environments.

Our network has supported studies relating to HIV, tuberculosis (TB), RSV, influenza and COVID-19, including high-volume vaccine studies and large-scale participant recruitment initiatives.

This includes one of the highest recruiting TB vaccine studies globally, with:

3000+

participants screened

1490

participants randomised

MERCLINCO is also the only African site network to receive the
SCRS SPRIA Award twice for innovation in patient recruitment.
Proven
Recruitment
Outcomes

MERCLINCO has supported recruitment across multiple therapeutic areas and patient populations, including infectious diseases, respiratory conditions and chronic illnesses.

Our sites have extensive experience conducting studies within real healthcare environments, supporting participant engagement and strong retention outcomes across multiple clinical trials.

Experienced Investigators
& Research Sites

MERCLINCO’s network includes experienced Principal Investigators, dedicated research teams and established clinical research sites operating across multiple African regions.

Our investigators have conducted clinical trials across a broad range of therapeutic areas, with experience spanning adult and paediatric studies, vaccine programmes and chronic disease management.

Sites are embedded within active healthcare environments, providing ongoing exposure to diverse patient populations and disease profiles relevant to global clinical research priorities.

Looking for
Clinical Research
Expertise
Across Africa

MERCLINCO supports Sponsors, CROs and SNOs through experienced investigators, diverse therapeutic expertise and established clinical research sites across Africa.